Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed Cagrilintide and Semaglutide Combo Highly Effective for Weight Loss Docwire News Cagrilintide Weight Loss Appetite Control and Fat Burning Support Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit CagriSema in Clinical Trials: What Patients Should Know Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 24 mg for weight management: a randomised, controlled, phase 1b trial The Lancet